Last reviewed · How we verify
NCT06008964
The Effect of Aromatherapy Applied After Cesarean Section on Pain Intensity and Comfort Level
NA trial testing Ylang Ylang oil with inhalation in Cesarean Section Complications in 96 participants. Completed in 25 October 2023.
17 August 2023
Quick facts
| Lead sponsor | KTO Karatay University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 96 |
| Start date | 15 June 2023 |
| Primary completion | 17 August 2023 |
| Estimated completion | 25 October 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Ylang Ylang oil with inhalation
- Lavender oil with inhalation
Conditions studied
- Cesarean Section Complications — all drugs for Cesarean Section Complications →
Sponsor
KTO Karatay University
Who can join
Adults 18 to 49, female only, with Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Today, many complementary therapies such as acupuncture, reflexology, homeopathy, hypnotherapy, music and aromatherapy are tried in addition to medical methods to reduce pain and anxiety. Aromatherapy is a therapy method in which essential oils are used to protect and improve physical and psychological health. Oils can be applied directly to a single person or indirectly to people in a room by inhalation . In direct application without steam, essential oils can be applied by inhalation by dripping onto a cotton ball . It is stated that lavender aromatherapy, one of the most commonly used aromatherapies, has analgesic, antiseptic, sedative, antispasmodic and healing properties Ylang Ylang aromatherapy is stated analgesic, anti-inflammatory, antimicrobial, antiemetic,anti-tarral, carminative, sedative, antiseptic, spasmolytic properties. In the studies conducted, anxiety, labor pain, labor duration, and psychological effects of aromatherapy were examined, but no study was found in which lavender and chamomile essential oils were used and the effects of pain and comfort level were examined. The aim of this study is to determine the effect of lavender and Ylang Ylang essential oils in relieving pain and increasing comfort after cesarean section.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06008964
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cesarean Section Complications
Currently open trials in the same condition.
- NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
- NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
- NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
- NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
- NCT07049705 — Factors Influencing Bradycardia During Spinal Anesthesia in Obstetric Patients Undergoing Cesarean Section · active not recruiting
Other KTO Karatay University trials
Trials by the same sponsor.
- NCT07533617 — Chair-Integrated Foam Modifications in Coccydynia · NA · enrolling by invitation
- NCT07532980 — Quadriceps and Hamstring Activation Timing · enrolling by invitation
- NCT07516743 — Acute Effects of Motor Imagery Exercises in Individuals With Pregnancy-Related Lumbopelvic Pain · NA · recruiting
- NCT07487987 — Acute Effects of Motor Imagery and Motor Control Exercises in Individuals With Chronic Neck Pain · NA · recruiting
- NCT07344896 — MBSR Effects on Aging Anxiety and Body Image · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06008964 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by KTO Karatay University
- Last refreshed: 26 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06008964.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing